FDA warns of deadly side effect with imaging drugs - KFDA - NewsChannel 10 / Amarillo News, Weather, Sports

FDA warns of deadly side effect with imaging drugs

WASHINGTON (AP) — Federal health regulators are warning that a class of injectable drugs used in medical imaging scans such as MRIs can cause a rare and sometimes fatal condition in patients with kidney disease.

The Food and Drug Administration is adding warning labels to imaging agents that contain the chemical gadolinium, saying they should not be used in patients with kidney problems.

The agency says the drugs can lead to a rare syndrome that causes hardening of the skin and tissue growth along joints, eyes and internal organs. The ailment is called nephrogenic fibrosing dermopathy and can be fatal. It is most common among patients with kidney failure.

Products subject to the warnings include Bayer Healthcare's Magnevist and GE Healthcare's Omniscan.

Powered by Frankly